反応式
[Cl:1][C:2]1[NH:11][C:10]2[C:9](=[O:12])[N:7]([CH3:8])[C:6](=[O:13])[N:5]([CH3:14])[C:4]=2[N:3]=1.[CH2:15](Br)[C:16]1[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=1.C(=O)([O-])[O-].[K+].[K+]>CN(C=O)C>[CH2:15]([N:11]1[C:10]2[C:9](=[O:12])[N:7]([CH3:8])[C:6](=[O:13])[N:5]([CH3:14])[C:4]=2[N:3]=[C:2]1[Cl:1])[C:16]1[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=1参加物
5
実験手順
8-Chlorotheophylline (50 g, 0.23 mol) was suspended in 600 ml of DMF and benzyl bromide (31 ml, 0.26 mol) and potassium carbonate (64 g, 0.46 mol) were added. The mixture was stirred at room temperature for 20 hours. The solvent was evaporated and the residue was dissolved in 250 ml of water and 400 ml of DCM. The layers were separated and the aqueous layer was extracted with 150 ml of DCM. The combined organic layer was washed with 100 ml of brine, dried over magnesium sulphate, filtered, and the solvent was evaporated to give compound (2A) as white crystals.
後処理
- customThe solvent was evaporated
- dissolutionthe residue was dissolved in 250 ml of water
- customThe layers were separated
- extractionthe aqueous layer was extracted with 150 ml of DCM
- washThe combined organic layer was washed with 100 ml of brine
- dry with materialdried over magnesium sulphate
- filtrationfiltered
- customthe solvent was evaporated
出典と根拠
- ORDレコード
- ord-c26a34518a48404cbf441d3815a4a8ab
- 出典データセット
- uspto-grants-2007_03
- 特許番号
- US07192952B2
関連ノート
読み込み中…